PUBLISHER: IMARC | PRODUCT CODE: 1451213
PUBLISHER: IMARC | PRODUCT CODE: 1451213
The global respiratory care devices market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Respiratory care devices refer to the medical equipment used for the diagnosis, treatment, assessment and care of patients suffering from pulmonary diseases. Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices. These devices primarily perform diagnostic, therapeutic and monitoring functions. They aid in ensuring a smooth respiration process by providing an adequate amount of oxygen to the lungs and preventing any blockage in the process.
The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and tuberculosis, represent as the key factors driving the growth of the market. Sedentary lifestyles and stressful routines, in confluence with the growing number of smokers and rate of alcohol consumption, have resulted in rising incidences of lung cancer and other severe respiratory conditions. Also, the increasing number of premature births, along with the growing geriatric population are also impacting the demand for respiratory care devices. Both premature newborns and elderly tend to have weak immune systems and require various breathing support devices for facilitating artificial breathing and preventing respiratory disorders, including newborn respiratory distress syndrome (RDS). Other factors, such as the increasing healthcare expenditure and the development of miniature devices are projected to drive the market further. Significant efforts by both the government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all, along with developing new and improving the existing healthcare infrastructure are also creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory care devices market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product, indication and end-user.
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Ventilators
Nebulizers
Humidifiers
Inhalers
Other
Monitoring Devices
Pulse Oximeters
Gas Analyzers
Others
Diagnostic Devices
Spirometers
Polysomnography Devices
Peak Flow Meters
Others
Consumables and Accessories
Masks
Disposable Resuscitators
Breathing Circuits
Tracheostomy Tubes
Nasal Cannulas
Others
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Sleep Apnea
Infectious Disease
Others
Hospitals
Home Care Settings
Ambulatory Care Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, ResMed, Chart Industries Inc., Hamilton Medical, Medtronic, Masimo, Dragerwerk, Invacare Corporation, Allied Healthcare Products Inc, 3B Medical Inc., Air Liquide, Fisher & Paykel Healthcare, GE Healthcare, Vyaire Medical Inc., Rotech Healthcare Inc., etc.